Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Riluzole

EU orphan designation number: EU/3/14/1401   
Active ingredient: Riluzole
Indication: Treatment of traumatic spinal cord injury
Sponsor: Dr Laurent Vinay
Institut des Neurosciences de la Timone, Campus Santé Timone, 27 bd Jean Moulin, 13385 Marseille cedex 05, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/12/2014 Orphan designation EMA/OD/186/14 (2014)10049 of 16/12/2014